Krüppel-like factor 4: A new potential biomarker of lung cancer

Fadous‑Khalifé,Marie  Claude; Aloulou,Nijez; Jalbout,Majida; Hadchity,Joseph; Aftimos,Georges; Paris,François; Hadchity,Elie

doi:10.3892/mco.2016.883

Krüppel-like factor 4: A new potential biomarker of lung cancer

Authors:
- Marie Claude Fadous‑Khalifé
- Nijez Aloulou
- Majida Jalbout
- Joseph Hadchity
- Georges Aftimos
- François Paris
- Elie Hadchity
View Affiliations

Affiliations: Anti‑Tumor Therapeutic Targeting Laboratory, Faculty of Sciences, Lebanese University, Hadath, Lebanon, Department of Surgery, Sainte Thérèse Hospital, Hadath, Lebanon, National Institute of Pathology, Baabda, Lebanon, Endothelium Radiobiology and Targeting, UMR Inserm 892, Cancer Research Center, Nantes, France
Published online on: April 28, 2016 https://doi.org/10.3892/mco.2016.883
Pages: 35-40
Copyright: © Fadous‑Khalifé et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is most prevalent human cancer worldwide. However, no molecular markers are currently available for predicting lung cancer prognosis. Therefore, identifying novel biomarkers may be useful for improving clinical diagnosis and patient stratification. Krüppel‑like factor 4 (KLF4) is a transcription factor with opposing roles in different human cancers. Its overexpression in several cancers is correlated with a poor prognosis. However, the expression and role of KLF4 in lung cancer remains to be elucidated. The aim of this study was to determine the profile of KLF4 expression in different types of lung cancer. The KLF4 protein expression level was tested and evaluated by immunohistochemical analysis in 47 lung tumors and normal tissues, and then correlated with clinical characteristics. A differential expression of KLF4 was observed between normal tissue and each of the lung cancer types. A significant decrease in KLF4 expression was observed in non‑small‑cell lung cancer (NSCLC) compared with that in normal tissue, while significant overexpression was detected in small‑cell lung cancer. Furthermore, a higher rate of expression was observed in stage II, III and IV disease compared with stage I disease in NSCLC tissues. KLF4 expression was not found to be associated with age or gender. Our results suggested that the KLF4 protein level may be a potential biomarker in patients with advanced lung cancer.

View Figures

View References

1.	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small-cell lung cancer: Epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Travis WD, Travis LB and Devesa SS: Lung cancer. Cancer. 75(1 Suppl): S191–S202. 1995. View Article : Google Scholar
3.	Preiss A, Rosenberg UB, Kienlin A, Seifert E and Jäckle H: Molecular genetics of Krüppel, a gene required for segmentation of the Drosophila embryo. Nature. 313:27–32. 1985. View Article : Google Scholar : PubMed/NCBI
4.	Dang DT, Pevsner J and Yang VW: The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol. 32:1103–1121. 2000. View Article : Google Scholar : PubMed/NCBI
5.	Black AR, Black JD and Azizkhan-Clifford J: Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 188:143–160. 2001. View Article : Google Scholar : PubMed/NCBI
6.	Kaczynski J, Cook T and Urrutia R: Sp1- and Krüppel-like transcription factors. Genome Biol. 4:2062003. View Article : Google Scholar : PubMed/NCBI
7.	Garrett-Sinha LA, Eberspaecher H, Seldin MF and de Crombrugghe B: A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem. 271:31384–31390. 1996. View Article : Google Scholar : PubMed/NCBI
8.	Shields JM, Christy RJ and Yang VW: Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem. 271:20009–20017. 1996. View Article : Google Scholar : PubMed/NCBI
9.	Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE and Yang VW: Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene. 23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 65:2746–2754. 2005. View Article : Google Scholar : PubMed/NCBI
11.	Wei D, Kanai M, Huang S and Xie K: Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 27:23–31. 2006. View Article : Google Scholar : PubMed/NCBI
12.	Nakahara Y, Northcott PA, Li M, Kongkham PN, Smith C, Yan H, Croul S, Ra YS, Eberhart C, Huang A, et al: Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia. 12:20–27. 2010. View Article : Google Scholar : PubMed/NCBI
13.	Yasunaga J, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, Sakai T, Mitsuya H and Matsuoka M: Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 64:6002–6009. 2004. View Article : Google Scholar : PubMed/NCBI
14.	Foster KW, Ren S, Louro ID, Lobo-Ruppert SM, McKie-Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT and Ruppert JM: Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: Transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10:423–434. 1999.PubMed/NCBI
15.	Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN and Wu M: Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer. World J Gastroenterol. 8:966–970. 2002. View Article : Google Scholar : PubMed/NCBI
16.	Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG and Fang B: Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res. 15:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T: Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
18.	Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE and Ruppert JM: Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60:6488–6495. 2000.PubMed/NCBI
19.	Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, et al: Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 10:2709–2719. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC and Chen CM: Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol Ther. 7:777–782. 2008. View Article : Google Scholar : PubMed/NCBI
21.	Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, et al: Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 24:1491–1500. 2005. View Article : Google Scholar : PubMed/NCBI
22.	Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM and Lobo-Ruppert SM: KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol Ther. 4:1401–1408. 2005. View Article : Google Scholar : PubMed/NCBI
23.	Yu T, Chen X, Zhang W, Liu J, Avdiushko R, Napier DL, Liu AX, Neltner JM, Wang C, Cohen D and Liu C: KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 23:207–215. 2016. View Article : Google Scholar : PubMed/NCBI
24.	Zhou Y, Hofstetter WL, He Y, Hu W, Pataer A, Wang L, Wang J, Zhou Y, Yu L, Fang B and Swisher SG: KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther. 9:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Naranjo Gómez JM, Bernal JF, Arranz PG, Fernández SL and Roman JJ: Alterations in the expression of p53, KLF4 and p21 in neuroendocrine lung tumors. Arch Pathol Lab Med. 138:936–942. 2014. View Article : Google Scholar : PubMed/NCBI
26.	Zhang Z, Wang Z, Liu X, Shi M, Chen G, Zhang B, Li Z and Song L: Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer. Chin J Lung Cancer. 720–724. 2012.(In Chinese).